The E318G substitution in PSEN1 gene is not connected with Alzheimer's disease in a large Polish cohort

被引:17
作者
Zekanowski, C
Peplonska, B
Styczynska, M
Religa, D
Pfeffer, A
Czyzewski, K
Gabryelewicz, T
Szybinska, A
Kijanowksa-Haladyna, B
Kotapka-Minc, S
Luczywek, E
Barczak, A
Wasiak, B
Chodakowska-Zebrowska, M
Przekop, I
Kuznicki, J
Barcikowksa, M
机构
[1] Int Inst Mol & Cell Biol, Lab Neurodegenerat, PL-02109 Warsaw, Poland
[2] Polish Acad Sci, Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland
[3] Karolinska Inst, Sect Expt Geriatr, Dept Neurotec, Stockholm, Sweden
[4] MSWiA Hosp, Dept Neurol, Warsaw, Poland
[5] Inst Psychiat & Neurol, Psychogeriatr Dept, Warsaw, Poland
[6] Polish Acad Sci, Med Res Ctr, Dept Neurosurg, Warsaw, Poland
[7] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland
关键词
E318G mutation; polymorphism; presenilin; 1; apolipoprotein E; Alzheimer's disease; Parkinson's disease; centenarians;
D O I
10.1016/j.neulet.2003.12.052
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mutations in the presenilin 1 (PSEN1) gene are known to cause nearly 50% of early-onset, familial Alzheimer's disease (AD) cases. To determine whether E318G mutation is related causally to AD in the Polish population E318G mutation frequency was assessed using PCR-RFLP method in a total of 659 subjects: 256 AD patients, 210 healthy, age-matched control subjects, 100 Parkinson's disease patients and 93 centenarians. When the mutation frequencies were compared to healthy controls, no significant differences between the groups were found. It could be concluded that E318G mutation is not related causally to AD in the Polish population, either as a risk factor or a disease causing mutation. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 21 条
[11]   ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES [J].
HUGHES, AJ ;
DANIEL, SE ;
KILFORD, L ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) :181-184
[12]   Early onset familial Alzheimer's disease - Mutation frequency in 31 families [J].
Janssen, JC ;
Beck, JA ;
Campbell, TA ;
Dickinson, A ;
Fox, NC ;
Harvey, RJ ;
Houlden, H ;
Rossor, MN ;
Collinge, J .
NEUROLOGY, 2003, 60 (02) :235-239
[13]  
Kowalska A, 2003, J APPL GENET, V44, P231
[14]   The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease [J].
Mattila, KM ;
Forsell, C ;
Pirttilä, T ;
Rinne, JO ;
Lehtimäki, T ;
Röyttä, M ;
Lilius, L ;
Eerola, A ;
St George-Hyslop, PH ;
Frey, H ;
Lannfelt, L .
ANNALS OF NEUROLOGY, 1998, 44 (06) :965-967
[15]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[16]   Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients [J].
Sandbrink, R ;
Zhang, D ;
Schaeffer, S ;
Masters, CL ;
Bauer, J ;
Forstl, H ;
Beyreuther, K .
ANNALS OF NEUROLOGY, 1996, 40 (02) :265-266
[17]   Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease [J].
Styczynska, M ;
Religa, D ;
Pfeffer, A ;
Luczywek, E ;
Wasiak, B ;
Styczynski, G ;
Peplonska, B ;
Gabryelewicz, T ;
Golebiowski, M ;
Kobrys, M ;
Barcikowska, M .
NEUROSCIENCE LETTERS, 2003, 344 (02) :99-102
[18]   Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease [J].
Taddei, K ;
Kwok, JBJ ;
Kril, JJ ;
Halliday, GM ;
Creasey, H ;
Hallupp, M ;
Fisher, C ;
Brooks, WS ;
Chung, C ;
Andrews, C ;
Masters, CL ;
Schofield, PR ;
Martins, RH .
NEUROREPORT, 1998, 9 (14) :3335-3339
[19]   Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population [J].
Taddei, K ;
Fisher, C ;
Laws, SM ;
Martins, G ;
Paton, A ;
Clarnette, RM ;
Chung, C ;
Brooks, WS ;
Hallmayer, J ;
Miklossy, J ;
Relkin, N ;
St George-Hyslop, PH ;
Gandy, SE ;
Martins, RN .
MOLECULAR PSYCHIATRY, 2002, 7 (07) :776-781
[20]   Presenilin and γ-secretase:: structure meets function [J].
Wolfe, MS .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (06) :1615-1620